BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 20478027)

  • 1. Analysis of prototype foamy virus particle-host cell interaction with autofluorescent retroviral particles.
    Stirnnagel K; Lüftenegger D; Stange A; Swiersy A; Müllers E; Reh J; Stanke N; Grosse A; Chiantia S; Keller H; Schwille P; Hanenberg H; Zentgraf H; Lindemann D
    Retrovirology; 2010 May; 7():45. PubMed ID: 20478027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential pH-dependent cellular uptake pathways among foamy viruses elucidated using dual-colored fluorescent particles.
    Stirnnagel K; Schupp D; Dupont A; Kudryavtsev V; Reh J; Müllers E; Lamb DC; Lindemann D
    Retrovirology; 2012 Aug; 9():71. PubMed ID: 22935135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and manipulation of foamy virus membrane interactions.
    Swiersy A; Wiek C; Zentgraf H; Lindemann D
    Cell Microbiol; 2013 Feb; 15(2):227-36. PubMed ID: 23051660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenesis of N-terminal residues of feline foamy virus Gag reveals entirely distinct functions during capsid formation, particle assembly, Gag processing and budding.
    Liu Y; Betts MJ; Lei J; Wei G; Bao Q; Kehl T; Russell RB; Löchelt M
    Retrovirology; 2016 Aug; 13(1):57. PubMed ID: 27549192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An N-terminal domain helical motif of Prototype Foamy Virus Gag with dual functions essential for particle egress and viral infectivity.
    Reh J; Stange A; Götz A; Rönitz M; Große A; Lindemann D
    Retrovirology; 2013 Apr; 10():45. PubMed ID: 23618494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A small-molecule-controlled system for efficient pseudotyping of prototype foamy virus vectors.
    Ho YP; Schnabel V; Swiersy A; Stirnnagel K; Lindemann D
    Mol Ther; 2012 Jun; 20(6):1167-76. PubMed ID: 22472951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orthoretroviral-like prototype foamy virus Gag-Pol expression is compatible with viral replication.
    Swiersy A; Wiek C; Reh J; Zentgraf H; Lindemann D
    Retrovirology; 2011 Aug; 8():66. PubMed ID: 21843316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cooperative function of arginine residues in the Prototype Foamy Virus Gag C-terminus mediates viral and cellular RNA encapsidation.
    Hamann MV; Müllers E; Reh J; Stanke N; Effantin G; Weissenhorn W; Lindemann D
    Retrovirology; 2014 Oct; 11():87. PubMed ID: 25292281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a conserved residue of foamy virus Gag required for intracellular capsid assembly.
    Eastman SW; Linial ML
    J Virol; 2001 Aug; 75(15):6857-64. PubMed ID: 11435565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foamy virus capsid assembly occurs at a pericentriolar region through a cytoplasmic targeting/retention signal in Gag.
    Yu SF; Eastman SW; Linial ML
    Traffic; 2006 Aug; 7(8):966-77. PubMed ID: 16749903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A unique spumavirus Gag N-terminal domain with functional properties of orthoretroviral matrix and capsid.
    Goldstone DC; Flower TG; Ball NJ; Sanz-Ramos M; Yap MW; Ogrodowicz RW; Stanke N; Reh J; Lindemann D; Stoye JP; Taylor IA
    PLoS Pathog; 2013 May; 9(5):e1003376. PubMed ID: 23675305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foamy virus budding and release.
    Hütter S; Zurnic I; Lindemann D
    Viruses; 2013 Apr; 5(4):1075-98. PubMed ID: 23575110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evolutionarily conserved positively charged amino acid in the putative membrane-spanning domain of the foamy virus envelope protein controls fusion activity.
    Pietschmann T; Zentgraf H; Rethwilm A; Lindemann D
    J Virol; 2000 May; 74(10):4474-82. PubMed ID: 10775583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The foamy virus envelope glycoproteins.
    Lindemann D; Goepfert PA
    Curr Top Microbiol Immunol; 2003; 277():111-29. PubMed ID: 12908770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the amino terminus of foamy virus Gag disrupt morphology and infectivity but do not target assembly.
    Life RB; Lee EG; Eastman SW; Linial ML
    J Virol; 2008 Jul; 82(13):6109-19. PubMed ID: 18434404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foamy virus envelope glycoprotein-mediated entry involves a pH-dependent fusion process.
    Picard-Maureau M; Jarmy G; Berg A; Rethwilm A; Lindemann D
    J Virol; 2003 Apr; 77(8):4722-30. PubMed ID: 12663779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foamy virus envelope glycoprotein is sufficient for particle budding and release.
    Shaw KL; Lindemann D; Mulligan MJ; Goepfert PA
    J Virol; 2003 Feb; 77(4):2338-48. PubMed ID: 12551971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of simian foamy virus type-1 vectors.
    Park J; Mergia A
    Cold Spring Harb Protoc; 2011 Sep; 2011(9):. PubMed ID: 21880822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of prototype foamy virus gag late assembly domain motifs and their role in particle egress and infectivity.
    Stange A; Mannigel I; Peters K; Heinkelein M; Stanke N; Cartellieri M; Göttlinger H; Rethwilm A; Zentgraf H; Lindemann D
    J Virol; 2005 May; 79(9):5466-76. PubMed ID: 15827161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foamy virus biology and its application for vector development.
    Lindemann D; Rethwilm A
    Viruses; 2011 May; 3(5):561-85. PubMed ID: 21994746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.